• Imaging agents

Detectnet Generic Name & Formulations

General Description

Copper Cu 64 dotatate 148MBq (4mCi); per vial; soln for IV inj.

Pharmacological Class

Radioactive diagnostic agent.

How Supplied

Single-dose vial—10mL


Generic Availability


Detectnet Indications


Use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adults.

Detectnet Dosage and Administration


See full labeling. Prep patient accordingly. Use within 2hrs after calibration time. Administer 148MBq (4mCi) as IV inj over approx. 1min, followed by an IV flush of NaCl 0.9% inj. Begin image acquisition 45–90mins after inj.


Not established.

Detectnet Contraindications

Not Applicable

Detectnet Boxed Warnings

Not Applicable

Detectnet Warnings/Precautions


Should be administered by experienced physicians who are qualified in the use of radionuclides. Must handle with appropriate safety measures to minimize radiation exposure. Radiation risk. Advise patients to hydrate before and after inj, and to void frequently after administration. Risk for image misinterpretation; increased uptake may be seen in other pathologic conditions (eg, thyroid disease, subacute inflammation) or as normal physiologic variant (eg, uncinate process of the pancreas). Hepatic or renal impairment. Elderly. Pregnancy: exclude status prior to administration. Nursing mothers: interrupt breastfeeding for 12hrs after administration.

Detectnet Pharmacokinetics

See Literature

Detectnet Interactions


Concomitant with long-acting somatostatin analogs: wash-out period of 28 days is recommended prior to imaging. Concomitant with short-acting somatostatin analogs: wash-out period of 2 days is recommended prior to imaging.

Detectnet Adverse Reactions

Adverse Reactions

Nausea, vomiting, flushing; hypersensitivity reactions.

Detectnet Clinical Trials

See Literature

Detectnet Note

Not Applicable

Detectnet Patient Counseling

See Literature